Clinical Trials Browser

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT06287814 2025-07-10

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

Recruiting

70 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT05196087 2025-07-02

NIP IT!

Recruiting

500 enrolled

BreastDermatologicEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

NCT06111105 2025-03-30

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

Recruiting

590 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT06449846 2024-06-10

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Not yet recruiting

152 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Neoplasm, Residual

NCT06404593 2024-05-08

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

Completed

270 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05219734 2024-03-12

MARIA

Active not recruiting

400 enrolled

GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT06287723 2024-03-01

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

Not yet recruiting

30 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05969938 2023-08-01

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Unknown

50 enrolled

Gastrointestinal

Rectal Neoplasms, Neoplasm, Residual

NCT05952661 2023-07-19

ECMRD-001

Recruiting

56 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasm, Residual

NCT05900583 2023-06-12

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Unknown

50 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm, Residual

NCT05867901 2023-05-31

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

Recruiting

40 enrolled

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

NCT05743959 2023-05-22

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Unknown

100 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT05408897 2022-09-21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Recruiting

45 enrolled

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

Clinical Trials

TRACE-BTC

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

NIP IT!

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

MARIA

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

ECMRD-001

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD